Dyadic International Inc., DE Stock, NASDAQ:DYAI
140 Intracoastal Pointe Drive, Suite 404, Jupiter, Florida 33477-5094
United States of America
Number of Employees: 7
Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.